Erst- und Seniorautorenschaften
Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial)
Sci Rep. 2023 Sep 18;13(1):15437. Breyer J, Eckstein M, Sikic D, Wezel F, Roghmann F, Brehmer M, Wirtz RM, Jarczyk J, Erben P, Bahlinger V, Goldschmidt F, Fechner G, Chen J, Paxinos E, Bates M, Haas M, Zengerling F, Bolenz C, Burger M, Hartmann A, Kriegmair MC; BRIDGE Consortium e.V.
Risk factors for bladder neck contracture after transurethral resection of the prostate.
Prostate. 2023 Aug;83(11):1020-1027. Goßler C, Pfänder F, Haas M, Mayr R, Gierth M, Burger M, Rosenhammer B, Breyer J
Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy
BJU Int. 2023 Aug;132(2):170-180. Claps F, van de Kamp MW, Mayr R, Bostrom PJ, Shariat SF, Hippe K, Bertz S, Neuzillet Y, Sanders J, Otto W, van der Heijden MS, Jewett MAS, Stöhr R, Zlotta AR, Trombetta C, Eckstein M, Mertens LS, Burger M, Soorojebally Y, Wullich B, Bartoletti R, Radvanyi F, Pavan N, Sirab N, Mir MC, Pouessel D, van der Kwast TH, Hartmann A, Lotan Y, Bussani R, Allory Y, van Rhijn BWG
Adrenal tumors: diagnostics, perioperative management and surgical treatment
Urologie. 2023 Feb;62(2):187-195. Engelmann S, Burger M, Mayr R
Endocrine immune-related adverse events in patients with metastatic renal and urothelial cancer treated with immune checkpoint-inhibitors
Int Urol Nephrol. 2023 Aug;55(8):1943-1949. Oppolzer IA, Riester J, Büttner R, Burger M, Schnabel MJ
Erratum to "European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel" [Eur. Urol. 79(4) (2021) 480-488]
Eur. Urol. 79(4) (2021) 480-488]. Eur Urol. 2023 May;83(5):e140-e141. Sylvester RJ, Rodríguez O, Hernández V, Turturica D, Bauerová L, Max Bruins H, Bründl J, van der Kwast TH, Brisuda A, Rubio-Briones J, Seles M, Hentschel AE, Kusuma VRM, Huebner N, Cotte J, Mertens LS, Volanis D, Cussenot O, Subiela Henríquez JD, de la Peña E, Pisano F, Pešl M, van der Heijden AG, Herdegen S, Zlotta AR, Hacek J, Calatrava A, Mannweiler S, Bosschieter J, Ashabere D, Haitel A, Côté JF, El Sheikh S, Lunelli L, Algaba F, Alemany I, Soria F, Runneboom W, Breyer J, Nieuwenhuijzen JA, Llorente C, Molinaro L, Hulsbergen-van de Kaa CA, Evert M, Kiemeney LALM, N'Dow J, Plass K, Čapoun O, Soukup V, Dominguez-Escrig JL, Cohen D, Palou J, Gontero P, Burger M, Zigeuner R, Mostafid AH, Shariat SF, Rouprêt M, Compérat EM, Babjuk M, van Rhijn BWG
Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?
Int Urol Nephrol. 2024 Apr;56(4):1323-1333. Beijert IJ, Hentschel AE, Bründl J, Compérat EM, Plass K, Rodríguez O, Subiela Henríquez JD, Hernández V, de la Peña E, Alemany I, Turturica D, Pisano F, Soria F, Čapoun O, Bauerová L, Pešl M, Bruins HM, Runneboom W, Herdegen S, Breyer J, Brisuda A, Calatrava A, Rubio-Briones J, Seles M, Mannweiler S, Bosschieter J, Kusuma VRM, Ashabere D, Huebner N, Cotte J, Contieri R, Mertens LS, Claps F, Masson-Lecomte A, Liedberg F, Cohen D, Lunelli L, Cussenot O, El Sheikh S, Volanis D, Côté JF, Rouprêt M, Haitel A, Shariat SF, Mostafid AH, Nieuwenhuijzen JA, Zigeuner R, Dominguez-Escrig JL, Hacek J, Zlotta AR, Burger M, Evert M, Hulsbergen-van de Kaa CA, van der Heijden AG, Kiemeney LALM, Soukup V, Molinaro L, Gontero P, Llorente C, Algaba F, Palou J, N'Dow J, Ribal MJ, van der Kwast TH, Babjuk M, Sylvester RJ, van Rhijn BWG
Short-Term and Long-Term Morbidity after Radical Cystectomy in Patients with NMIBC and Comparison with MIBC: Identifying Risk Factors for Severe Short-Term Complications
Urol Int. 2023;107(3):246-256. Haas M, Knobloch C, Mayr R, Gierth M, Pickl C, Engelmann S, Denzinger S, Burger M, Breyer J, Holbach S
Body Composition as a Comorbidity-Independent Predictor of Survival following Nephroureterectomy for Urothelial Cancer of the Upper Urinary Tract
Cancers (Basel). 2023 Jan 10;15(2):450. Pickl C, Engelmann S, Girtner F, Gužvić M, van Rhijn BWG, Hartmann V, Holbach S, Kälble S, Haas M, Rosenhammer B, Breyer J, Burger M, Mayr R
Open Pyeloplasty in Infants under 1 Year-Proven or Meaningless?
Children (Basel). 2023 Jan 31;10(2):257. Vauth F, Zöhrer P, Girtner F, Rösch WH, Hofmann A
Ureterocystoplasty in Boys with Valve Bladder Syndrome-Is This Method Still up to Date?
Children (Basel). 2023 Apr 6;10(4):692. Hofmann A, Ioannou A, Zöhrer PI, Rösch WH
Between wish and reality: more efficiency through increased outpatient procedures in paediatric urology
Aktuelle Urol. 2023 Apr;54(2):123-128. Hofmann A, Badelt G, Rösch WH
Co-Autorenschaften
Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Facult
Eur Urol. 2023 Oct;84(4):381-389. Bamias A, Stenzl A, Brown SL, Albiges L, Babjuk M, Birtle A, Briganti A, Burger M, Choudhury A, Colecchia M, De Santis M, Fanti S, Fonteyne V, Gallucci M, Rivas JG, Huddart R, Junker K, Kroeze S, Loriot Y, Merseburger A, Montironi R, Necchi A, Oing C, Oldenburg J, Ost P, Pinkawa M, Ribal MJ, Rouprêt M, Thoeny H, Zilli T, Hoskin P
International Opinions on Grading of Urothelial Carcinoma: A Survey Among European Association of Urology and International Society of Urological Pathology Members
Eur Urol Open Sci. 2023 May 10;52:154-165Beijert IJ, Cheng L, Liedberg F, Plass K, Williamson SR, Gontero P, Ribal MJ, Babjuk M, Black PC, Kamat AM, Algaba F, Berman DM, Hartmann A, Masson-Lecomte A, Rouprêt M, Lopez-Beltran A, Samaratunga H, Shariat SF, Mostafid AH, Varma M, Shen S, Burger M, Tsuzuki T, Palou J, Compérat EM, Sylvester RJ, van der Kwast TH, van Rhijn BWG, Downes MR
Evaluation of Gas 6 as a Prognostic Marker in Papillary Renal Cell Carcinoma
Urol Int. 2023;107(7):713-722. Mikuteit M, Zschäbitz S, Stöhr C, Herrmann E, Polifka I, Agaimy A, Trojan L, Ströbel P, Becker F, Wülfing C, Barth P, Stöckle M, Staehler M, Stief C, Haferkamp A, Hohenfellner M, Duensing S, Macher-Göppinger S, Wullich B, Noldus J, Brenner W, Roos F, Walter B, Otto W, Burger M, Erlmeier M, Schrader AJ, Hartmann A, Erlmeier F, Steffens S; German Network Of Kidney Cancer
Patient Benefits of Radical Prostatectomy in Certified Prostate Cancer Centers: Comparative Results from the Multicenter IMPROVE Study
Int. 2023;107(10-12):949-958. Sikic D, Fiebig C, Wullich B, Wolff I, Hoschke B, Manseck A, Gillitzer R, Burger M, Steinestel J, Harke N, Löbig N, Distler FA, May M, Peter J, Gilfrich C
Centralizing Penile Cancer Care in Germany and Austria: Just a Dream or a Fast-Approaching Reality? Results of a Survey Study among Urological Department Chairs and Modeling of Real Treatment Numbers of Penile Cancer Patients
Urol Int. 2023;107(10-12):916-923. Yakac A, Lebentrau S, Lusuardi L, Sarcan S, Burger M, Merseburger AS, Wiegland J, Gilfrich C, Wolff I, Ahyai S, May M, Thomas C
Patient's Desire and Real Availability Concerning Supportive Measures Accompanying Radical Prostatectomy: Differences between Certified Prostate Cancer Centers and Non-Certified Centers Based on Patient-Reported Outcomes within the Cross-Sectional Study Improve
Cancers (Basel). 2023 May 19;15(10):2830. Wolff I, Burchardt M, Peter J, Thomas C, Sikic D, Fiebig C, Promnitz S, Hoschke B, Burger M, Schnabel MJ, Gilfrich C, Löbig N, Harke NN, Distler FA, May M
Critical Evaluation of a microRNA-Based Risk Classifier Predicting Cancer-Specific Survival in Renal Cell Carcinoma with Tumor Thrombus of the Inferior Vena Cava
Cancers (Basel). 2023 Mar 26;15(7):1981. Kotlyar MJ, Krebs M, Solimando AG, Marquardt A, Burger M, Kübler H, Bargou R, Kneitz S, Otto W, Breyer J, Vergho DC, Kneitz B, Kalogirou C
Weitere Infos zu dieser Publikation
Effects of Individualised High Positive End-Expiratory Pressure and Crystalloid Administration on Postoperative Pulmonary Function in Patients Undergoing Robotic-Assisted Radical Prostatectomy: A Prospective Randomised Single-Blinded Pilot Study
J Clin Med. 2023 Feb 12;12(4):1460. Blecha S, Hager A, Gross V, Seyfried T, Zeman F, Lubnow M, Burger M, Pawlik MT
Are there any volume-related effects on treatment options for patients with penile cancer? Results of a survey among university hospitals in Germany and Austria
Aktuelle Urol. 2023 Aug;54(4):285-291.Lebentrau S, Yakac A, Lusuardi L, Thomas C, Sarcan S, Burger M, Merseburger AS, Wiegland J, Gilfrich C, Wolff I, May M
Integrated single-cell profiling dissects cell-state-specific enhancer landscapes of human tumor-infiltrating CD8(+) T cells
Mol Cell. 2023 Feb 16;83(4):622-636.Riegel D, Romero-Fernández E, Simon M, Adenugba AR, Singer K, Mayr R, Weber F, Kleemann M, Imbusch CD, Kreutz M, Brors B, Ugele I, Werner JM, Siska PJ, Schmidl C
A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinoma
Front Immunol. 2023 Mar 16;14:1095195. Pichler R, Siska PJ, Tymoszuk P, Martowicz A, Untergasser G, Mayr R, Weber F, Seeber A, Kocher F, Barth DA, Pichler M, Thurnher M
Impact of Peritoneal Interposition Flap on Patients Undergoing Robot-assisted Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Eur Urol Focus. 2024 Jan;10(1):80-89. May M, Gilfrich C, Bründl J, Ubrig B, Wagner JR, Gloger S, Student V Jr, Merseburger AS, Thomas C, Brookman-May SD, Wolff I
PD-L1 (CD274) promoter hypomethylation predicts immunotherapy response in metastatic urothelial carcinoma
Oncoimmunology. 2023 Oct 19;12(1):2267744. Klümper N, Wüst L, Saal J, Ralser DJ, Zarbl R, Jarczyk J, Breyer J, Sikic D, Wullich B, Bolenz C, Roghmann F, Hölzel M, Ritter M, Strieth S, Hartmann A, Erben P, Wirtz RM, Landsberg J, Dietrich D, Eckstein M
Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution
Eur Urol. 2024 Apr;85(4):328-332. Cox A, Klümper N, Stein J, Sikic D, Breyer J, Bolenz C, Roghmann F, Erben P, Wirtz RM, Wullich B, Ritter M, Hölzel M, Schwamborn K, Horn T, Gschwend J, Hartmann A, Weichert W, Erlmeier F, Eckstein M
Impact of patients' health insurance status on the type of radical prostatectomy for localized prostate cancer in Germany: An observational analysis based on the multicentric IMPROVE study
J Surg Oncol. 2024 Feb;129(2):447-448. May M, Gilfrich C, Löbig N, Schnabel M, Wolff I
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update
Eur Urol. 2023 Jul;84(1):49-64. Rouprêt M, Seisen T, Birtle AJ, Capoun O, Compérat EM, Dominguez-Escrig JL, Gürses Andersson I, Liedberg F, Mariappan P, Hugh Mostafid A, Pradere B, van Rhijn BWG, Shariat SF, Rai BP, Soria F, Soukup V, Wood RG, Xylinas EN, Masson-Lecomte A, Gontero P
Recent developments in perioperative combination therapy in muscle-invasive bladder cancer
Curr Opin Urol. 2023 Sep 1;33(5):404-411. Mellema JJ, van Rhijn BWG, van der Heijden MS
High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial
Nat Med. 2023 Mar;29(3):588-592van Dorp J, Pipinikas C, Suelmann BBM, Mehra N, van Dijk N, Marsico G, van Montfoort ML, Hackinger S, Braaf LM, Amarante T, van Steenis C, McLay K, Daletzakis A, van den Broek D, van de Kamp MW, Hendricksen K, de Feijter JM, Boellaard TN, Meijer RP, van der Heijden AG, Rosenfeld N, van Rhijn BWG, Jones G, van der Heijden MS
Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer
Eur Urol. 2023 Apr;83(4):313-317. Gil-Jimenez A, van Dorp J, Contreras-Sanz A, van der Vos K, Vis DJ, Braaf L, Broeks A, Kerkhoven R, van Kessel KEM, Ribal MJ, Alcaraz A, Wessels LFA, Seiler R, Wright JL, Mengual L, Boormans J, van Rhijn BWG, Black PC, van der Heijden MS
Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional Cohort
J Urol. 2023 May;209(5):882-889. Kirk PS, Lotan Y, Zargar H, Fairey AS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobson NE, Montgomery JS, Vasdev N, Yu EY, Xylinas E, Kassouf W, Dall'Era MA, Sridhar SS, McGrath JS, Aning J, Shariat SF, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Grivas P, Garcia JA, Stephenson AJ, Shah JB, Daneshmand S, Spiess PE, van Rhijn BWG, Mertens L, Black P, Wright JL
Bladder Recurrence Following Upper Tract Surgery for Urothelial Carcinoma: A Contemporary Review of Risk Factors and Management Strategies
Eur Urol Open Sci. 2023 Jan 28;49:60-66. Mertens LS, Sharma V, Matin SF, Boorjian SA, Houston Thompson R, van Rhijn BWG, Masson-Lecomte A
Carboplatin Induction Chemotherapy in Clinically Lymph Node-positive Bladder Cancer
Eur Urol Open Sci. 2023 Mar 25;51:39-46. von Deimling M, Mertens LS, van Rhijn BWG, Lotan Y, Spiess PE, Daneshmand S, Black PC, Pallauf M, D'Andrea D, Moschini M, Soria F, Del Giudice F, Afferi L, Laukhtina E, Yanagisawa T, Kawada T, Teoh JY, Abufaraj M, Ploussard G, Roumiguié M, Karakiewicz PI, Babjuk M, Gontero P, Xylinas E, Rink M, Shariat SF, Pradere B
Electronic health record and research; happy marriage or early divorce?
BJU Int. 2024 Feb;133 Suppl 3:75. Scheltema MJ, van Rhijn BWG
Proposal for a Novel Histological Scoring System as a Potential Grading Approach for Muscle-invasive Urothelial Bladder Cancer Correlating with Disease Aggressiveness and Patient Outcomes
Eur Urol Oncol. 2024 Feb;7(1):128-138. Eckstein M, Matek C, Wagner P, Erber R, Büttner-Herold M, Wild PJ, Taubert H, Wach S, Sikic D, Wullich B, Geppert CI, Compérat EM, Lopez-Beltran A, Montironi R, Cheng L, van der Kwast T, Colecchia M, van Rhijn BWG, Amin MB, Netto GJ, Lehmann J, Stöckle M, Junker K, Hartmann A, Bertz S
Staging fluorodeoxyglucose positron emission tomography/computed tomography for muscle-invasive bladder cancer: a nationwide population-based study
BJU Int. 2023 Oct;132(4):420-427. Richters A, van Ginkel N, Meijer RP, Wondergem M, Schoots I, Vis AN, Kiemeney LALM, van Rhijn BWG, Witjes JA, Aben KKH, Mertens LS
Considering the Effects of Modern Point-of-Care Urine Biomarker Assays in Follow-Up of Patients with High-Risk Non-muscle-Invasive Bladder Cancer
Methods Mol Biol. 2023;2684:199-212. Ecke TH, Benderska-Söder N, Bismarck E, van Rhijn BWG, Todenhöfer T, Schmitz-Dräger BJ
Added Clinical Value of (18)F-FDG-PET/CT to Stage Patients With High-Risk Non-Muscle Invasive Bladder Cancer Before Radical Cystectomy
Clin Genitourin Cancer. 2023 Jun;21(3):342-348. van Ginkel N, van Gennep EJ, Oosterbaan L, Greidanus J, Boellaard TN, Wondergem M, Vis AN, de Reijke TM, van Rhijn BWG, Mertens LS
Clinical value of preoperative serum tumor markers CEA, CA19-9, CA125, and CA15-3 in surgically treated urachal cancer
Urol Oncol. 2023 Jul;41(7):326.e17-326. Stokkel LE, van Rossum HH, van de Kamp MW, Boellaard TN, Bekers EM, Kok NFM, van Rhijn BWG, Mertens LS
The Implementation of FDG PET/CT for Staging Bladder Cancer: Changes in the Detection and Characteristics of Occult Nodal Metastases at Upfront Radical Cystectomy?
J Clin Med. 2023 May 9;12(10):3367. Einerhand SMH, Zuur LG, Wondergem MJ, Boellaard TN, Barwari K, van Leeuwen PJ, van Rhijn BWG, Mertens LS
Corrigendum to "Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer" [Eur Urol 2023;83:313-17]
[Eur Urol 2023;83:313-17]. Eur Urol. 2023 Jun;83(6):e165. Gil-Jimenez A, van Dorp J, Contreras-Sanz A, van der Vos K, Vis DJ, Braaf L, Broeks A, Kerkhoven R, van Kessel KEM, Ribal MJ, Alcaraz A, Wessels LFA, Seiler R, Wright JL, Mengual L, Boormans J, van Rhijn BWG, Black PC, van der Heijden MS
Corrigendum to "Proposal for a Novel Histological Scoring System as a Potential Grading Approach for Muscle-invasive Urothelial Bladder Cancer Correlating with Disease Aggressiveness and Patient Outcomes" [European Urology Oncology (2023)]
[European Urology Oncology (2023)]. Eur Urol Oncol. 2023 Dec;6(6):641. Eckstein M, Matek C, Wagner P, Erber R, Büttner-Herold M, Wild PJ, Taubert H, Wach S, Sikic D, Wullich B, Geppert CI, Compérat EM, Lopez-Beltran A, Montironi R, Cheng L, van der Kwast T, Colecchia M, van Rhijn BWG, Amin MB, Netto GJ, Lehmann J, Stöckle M, Junker K, Hartmann A, Bertz S
Can ChatGPT Realistically and Reproducibly Assess the Difficulty Level of Written Questions in the In-Service Assessment of the European Board of Urology?
Urology, 2023 Jul;177:29-33.May M, Körner-Riffard K, Kollitsch L
Would Uro_Chat, a Newly Developed Generative Artificial Intelligence Large Language Model, Have Successfully Passed the In-Service Assessment Questions of the European Board of Urology in 2022?
Eur Urol Oncol. 2024 Feb;7(1):155-156. May M, Körner-Riffard K, Marszalek M, Eredics K
Histomorphometry of the Sural Nerve for Use as a CFNG in Facial Reanimation Procedures
J Clin Med. 2023 Jul 12;12(14):4627. Kehrer A, Hollmann KS, Klein SM, Anker AM, Tamm ER, Prantl L, Engelmann S, Knoedler S, Knoedler L, Ruewe M
The masseteric nerve for facial reanimation: Macroscopic and histomorphometric characteristics in 106 human cadavers and comparison of axonal ratio with recipient nerves
J Craniomaxillofac Surg. 2024 Jan;52(1):8-13. Kehrer A, Engelmann S, Knoedler L, Klein SM, Anker AM, Heidekrueger P, Tamm E, Bleys RL, Prantl L, Ruewe M
A program of successive gene expression in mouse one-cell embryos
Cell Rep. 2023 Feb 28;42(2):112023. Asami M, Lam BYH, Hoffmann M, Suzuki T, Lu X, Yoshida N, Ma MK, Rainbow K, Gužvić M, VerMilyea MD, Yeo GSH, Klein CA, Perry ACF
Exome Survey and Candidate Gene Re-Sequencing Identifies Novel Exstrophy Candidate Genes and Implicates LZTR1 in Disease Formation
Biomolecules. 2023 Jul 13;13(7):1117. Köllges R, Stegmann J, Schneider S, Waffenschmidt L, Fazaal J, Breuer K, Hilger AC, Dworschak GC, Mingardo E, Rösch W, Hofmann A, Neissner C, Ebert AK, Stein R, Younsi N, Hirsch-Koch K, Schmiedeke E, Zwink N, Jenetzky E, Thiele H, Ludwig KU, Reutter H
Core outcome domains for lichen sclerosus: a CORALS initiative consensus statement
Br J Dermatol. 2023 Apr 20;188(5):628-635. Simpson RC, Kirtschig G, Selk A, von Seitzberg S, Vittrup G, Bissonnette I, Kottner J, Lanthier J, Stanton C, Foster D, Promm M, Augenti A, Lauretti S, Thomas KS
